HAI Solutions News
HAI Solutions launches QIKswab™, a 3.15% CHG / 70% IPA swab for the scrub before access
Pre-moistened, individually sealed swabs in IV-pole strips of 2 or 6, so the 5-second hub scrub is within reach at every access.
HAI Solutions issued U.S. patent for RFID-enabled QIKcap platform
U.S. Patent 12,714,760 covers RFID integration that gives every QIKcap cap its own identity, a step toward an AI-enabled platform for IV connector care.
New: the QIKulator for value analysis committees
A free online calculator that models what a QIKcap subscription would cost your facility and how many CABSIs it would need to prevent to break even.
HAI Solutions Receives FDA De Novo Grant for QIKcap System: Pioneering UV-C Technology for Microbial Reduction on Needleless IV Connectors
This De Novo Grant is a HUGE accomplishment for the HAI Solutions team!
HAI Solutions Submits QIKCAP® System for FDA Regulatory Review
This submission marks a major achievement for our team as we work to deliver a next-generation IV port disinfection.
HAI Solutions Announced as Winner of AANA’s Inaugural Rm8 iNov8 Pitch Competition
Winning the Rm8 iNov8 competition is an incredible honor. To share my personal journey on a national stage and have the opportunity to potentially help millions as a future outcome is a dream come true
HAI Solutions Receives Notice of Allowance for Intravenous Device
HAI Solutions, a startup medical device company, focused on innovative vascular access solutions, announced today that the United States Patent and Trademark Office has issued a notice of allowance for claims related to the company's intravenous vascular access device.
Swimming with Sharks
This year’s Swimming with Sharks was conducted in collaboration with AngelMD and focused on innovations in the perioperative space. Learn more about HAI Solutions’ participation and pitch of the MDD-Multiport Delivery Device.
We’ve Launched our New Website!
Check out our New Website! Take a deep dive into our Story and Vision to improve healthcare and intravenous therapy in the operating room, emergency room and intensive care units.